Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients.


Journal Article

Three renal transplant recipients developed potentially life-threatening hyperkalemia after receiving intravenous labetalol for postoperative hypertension. Even as beta-adrenergic agonists find increasing use in the therapy of acute hyperkalemia, physicians should be aware of the potential of beta blockers to cause profound elevations of serum potassium.

Full Text

Duke Authors

Cited Authors

  • Arthur, S; Greenberg, A

Published Date

  • June 1, 1990

Published In

Volume / Issue

  • 33 / 6

Start / End Page

  • 269 - 271

PubMed ID

  • 2376088

Pubmed Central ID

  • 2376088

International Standard Serial Number (ISSN)

  • 0301-0430


  • eng